Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.1 USD | +2.04% | -1.27% | -17.16% |
04-11 | North American Morning Briefing : Stock Futures -2- | DJ |
04-10 | Wolfe Research Upgrades Ionis Pharmaceuticals to Outperform From Peer Perform | MT |
Business Summary
Number of employees: 927
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Therapeutic Medicines
100.0
%
| 587 | 100.0 % | 788 | 100.0 % | +34.10% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 587 | 100.0 % | 788 | 100.0 % | +34.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
D. Walke
FOU | Founder | 58 | 12-06-30 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 62 | 00-04-30 |
Eugene Schneider
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjay Bhanot
CTO | Chief Tech/Sci/R&D Officer | - | 99-12-31 |
Joel Ekstorm
CTO | Chief Tech/Sci/R&D Officer | - | - |
Tracy Berns
CMP | Compliance Officer | - | - |
C. Bennett
CTO | Chief Tech/Sci/R&D Officer | 67 | 88-12-31 |
B. Parshall
BRD | Director/Board Member | 70 | 91-10-31 |
Dave Ecker
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
CHM | Chairman | 72 | 14-02-02 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Joan Herman
BRD | Director/Board Member | 70 | 19-06-09 |
Joseph Klein
BRD | Director/Board Member | 62 | 05-12-12 |
B. Parshall
BRD | Director/Board Member | 70 | 91-10-31 |
Joseph Wender
BRD | Director/Board Member | 79 | 93-12-31 |
Director/Board Member | 71 | 02-04-30 | |
Michael Hayden
BRD | Director/Board Member | 72 | 18-09-23 |
Allene Diaz
BRD | Director/Board Member | 59 | 21-06-02 |
Michael Yang
BRD | Director/Board Member | 62 | 12-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 145,845,852 | 144,575,616 ( 99.13 %) | 0 | 99.13 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.16% | 6.02B | |
-0.38% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.61% | 24.63B | |
-23.52% | 18.2B | |
+26.81% | 12.01B | |
-3.17% | 11.76B | |
+14.30% | 10.4B | |
-3.93% | 9.94B |
- Stock Market
- Equities
- IONS Stock
- Company Ionis Pharmaceuticals, Inc.